Increased rates of arterial thromboembolism in cancer patients Presented ByDr Frits Mulder, Amsterdam UMC, University of Amsterdam, the Netherlands ConferenceISTH 2020 8 September, 2020 15:59
Risk of checkpoint inhibitor-associated thromboembolic events important for cancer prognosis Presented ByDr Florian Moik, Medical university of Vienna, Austria TrialCohort study ConferenceISTH 2020 8 September, 2020 15:44
Apixaban offers new perspective for cancer patients in need of anticoagulation Presented ByProf. G. Agnelli, University of Perugia, Italy TrialPhase 3, CARAVAGGIO ConferenceACC 2020 7 September, 2020 23:13
Immune-related AEs due to checkpoint inhibitors require care coordination ConferenceEULAR 2020 14 August, 2020 09:49
IL-6 and C-reactive protein as potential biomarkers for checkpoint inhibition Presented ByDr Jeffrey S. Weber, Laura and Isaac Perlmutter Cancer Centre, USA TrialCheckMate-064, CheckMate-066, CheckMate-067 ConferenceASCO 2019 15 July, 2019 23:55